Legible Prescriptions and the Right to Health: What the Punjab & Haryana High Court Ruling Means for Doctors

Illegible handwriting has been a running joke about doctors for generations — familiar enough to feel harmless. A August 2025 Punjab and Haryana High Court ruling treated it as something considerably more serious: a matter engaging the constitutional Right to Health. The resulting NMC directive, issued in December 2025, now requires every medical college in India to actively monitor prescription legibility as an institutional compliance obligation. This article explains the ruling, what the NMC has actually mandated in response, and what it means for practising doctors and colleges alike.

The Case: Yogesh v. State of Haryana

In its order dated August 27, 2025, in the matter of Yogesh v. State of Haryana (CRM-M-30305-2024), the Punjab and Haryana High Court observed that a legible medical prescription — or medical document more broadly — is an essential component of the Right to Health under Article 21 of the Constitution of India. The Court grounded this observation in existing statutory and regulatory provisions rather than creating an entirely new obligation from scratch: it specifically referenced the National Medical Commission Act, 2019, the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, and an MCI Notification dated September 21, 2016 — all of which the Court noted already mandate that every medical practitioner write prescriptions legibly and preferably in capital letters.

Why This Matters: Elevating an Existing Rule, Not Creating a New One

This is the most important legal nuance in the ruling. The requirement to write legibly, preferably in capital letters, was not new — it traces back to Clause 1.5 of the operative 2002 Code (as amended), discussed in more detail in the companion article on generic prescribing. What the Punjab and Haryana High Court did was reframe that existing ethical obligation in explicitly constitutional terms, tying illegible prescriptions to a violation of the Right to Health rather than treating it as a minor professional courtesy. This reframing carries real practical weight — a constitutional right is enforceable through writ jurisdiction and carries a different institutional urgency than a comparatively obscure clause in a decades-old ethics regulation that had, in practice, gone largely unenforced.

The NMC’s Response: A New Institutional Compliance Structure

On December 11, 2025, the NMC’s Postgraduate Medical Education Board issued a directive requiring every medical college and institution in India to constitute a Sub-Committee under their existing Drugs and Therapeutics Committee (DTC), specifically tasked with monitoring prescription practices. The DTC itself is not a new body — it is a multidisciplinary committee that already exists in most medical institutions to oversee medicine use, develop drug policies, and promote safe, rational prescribing. What’s new is the specific sub-committee mandate focused on legibility and generic-name compliance.

What the Sub-Committee Is Actually Required to Do

• Develop a structured plan for systematic appraisal of prescriptions to assess compliance with applicable regulations and guidelines.
• Review and analyse prescription patterns across the institution, identify deviations from the legibility and generic-name standards, and recommend corrective measures.
• Document all findings from prescription appraisals in the minutes of DTC meetings, which must be made available to the NMC on request.
• Ensure timely implementation of measures to comply with both the court order and the underlying existing regulations.

Separately, the NMC has mandated that medical colleges incorporate the topic “Importance of Legible and Clear Handwriting in Medical Prescriptions” directly into the curriculum for all students — treating this not just as an administrative monitoring exercise, but as something that needs to be actively taught and reinforced during training, rather than assumed to develop naturally through clinical practice.

Why This Is a Meaningfully Different Enforcement Model

Much of Indian medical regulation, as covered throughout this series, tends to be complaint-driven — a patient, family member, or competitor files a specific complaint, which then triggers a State Medical Council or NMC inquiry into that individual case. The DTC sub-committee model is structurally different: it requires proactive, systematic, institution-wide auditing of prescription practices as a standing compliance function, with documented findings available to the NMC on request, rather than waiting for an individual complaint to surface a problem. This is a more preventive, data-driven enforcement approach than much of the rest of the ethics framework currently uses.

What This Means for Practising Doctors, Not Just Students

While the specific NMC directive is addressed to medical colleges and their curricula, the underlying legal principle — that illegible prescriptions implicate the Right to Health — applies to the conduct of any registered medical practitioner, not just students in training. A practising doctor whose handwriting is genuinely difficult to read is not shielded from this reasoning simply because they are past their training years; if anything, the constitutional framing the Court applied strengthens the case that any doctor’s illegible prescription could be scrutinised more seriously than before, whether raised in a medical negligence context, a medical council complaint, or a pharmacy dispensing error traced back to misread handwriting.

The Practical Risk of Illegible Prescriptions Beyond Ethics Compliance

Illegible handwriting has always carried a real clinical risk — a pharmacist misreading a drug name or dosage is a well-documented category of medication error internationally, and this connects directly to the medical negligence and consumer protection framework covered elsewhere in this series. A prescription that leads to a dispensing error because it was genuinely unreadable strengthens, rather than weakens, a patient’s position in any subsequent negligence claim, since the doctor’s own documentation becomes evidence working against them rather than supporting their standard of care.

How This Connects to E-Prescriptions

This ruling adds a fresh, practical argument for clinics moving toward digital or electronic prescribing, covered in more depth in a companion article — a properly generated e-prescription eliminates the legibility question entirely, since the text is typed rather than handwritten. Clinics still relying primarily on handwritten prescriptions should treat this ruling as an additional reason, alongside the general efficiency and record-keeping benefits, to accelerate that transition.

A Practical Checklist

1. If you are affiliated with a medical college, confirm whether your institution’s DTC sub-committee has been constituted and is actively functioning, since this is now a specific, checkable NMC compliance requirement.
2. Honestly assess your own prescription handwriting — if legibility is a genuine issue, treat correcting it as a compliance priority, not a personal quirk.
3. Where possible, transition toward generating prescriptions digitally or in clearly printed form, which sidesteps the legibility question entirely.
4. If you supervise junior doctors or students, actively reinforce legible, generic-name prescribing as part of their training, consistent with the NMC’s curriculum mandate.
5. Keep this ruling in mind alongside the broader informed consent and documentation standards covered elsewhere in this series — legible records are foundational to defensible clinical documentation generally, not just to this specific compliance requirement.

Frequently Asked Questions

Is the requirement to write legible prescriptions a new rule created by this court case?

No. The underlying obligation already existed under the 2002 Code and a 2016 MCI notification; what the Punjab and Haryana High Court did was frame that existing obligation as an essential component of the constitutional Right to Health, giving it renewed institutional weight and prompting the NMC’s new monitoring mandate.

Does the NMC’s December 2025 directive apply only to medical students, or to practising doctors too?

The specific directive is addressed to medical colleges regarding curriculum and institutional monitoring, but the underlying legal and ethical obligation to write legibly applies to any registered medical practitioner, not only those still in training.

What is a DTC sub-committee, and is it a new body?

The Drugs and Therapeutics Committee itself is an existing multidisciplinary body in most medical institutions; the sub-committee specifically tasked with prescription legibility and compliance monitoring is the new element introduced by the NMC’s December 2025 directive.

Can an illegible prescription be used as evidence in a medical negligence case?

Potentially, yes — poor documentation, including illegibility that contributes to a dispensing or treatment error, can work against a doctor’s position in a negligence claim, since it undermines rather than supports evidence of careful, standard-meeting practice.

Does moving to digital or e-prescriptions solve this compliance issue?

It addresses the legibility concern directly, since typed or printed prescriptions remove ambiguity about handwriting, though clinics should also ensure their e-prescription system otherwise complies with the digital validity requirements covered in a companion article.

Researched Sources

1. Medical Dialogues — NMC Directs Medical Colleges to Set Up Prescription Monitoring Committees, Include Legible Prescribing Importance in Curriculum
2. National Medical Commission — Official Directive No. NMC/LEGAL/25436 on Legible Prescriptions
3. Business Standard — NMC Asks Colleges to Set Up Panels to Track Prescription Practices
4. MedBound Times — NMC Directs Medical Colleges to Monitor Prescriptions and Ensure Legible Handwriting

Disclaimer

This article is for general informational and educational purposes and reflects the court ruling and NMC directive as understood at the time of writing. It is not legal advice; doctors and institutions should consult a qualified healthcare lawyer or refer to the official NMC directive for complete compliance requirements.